GYS2 and cancer: First, we performed an integrated pan-cancer analysis of GYS2 in the GEPIA database and found that the expression of GYS2 was significantly down-regulated in a variety of human tumors (Figure 1(a)), especially in hepatobiliary tumors (Figure 1(b)), compared with corresponding normal tissues.